The causal association between neutrophil proteinase activity and AATD-associated lung disease is well described [3], and lung disease can be slowed using Alpha 1 Antitrypsin (AAT) augmentation therapy, replacing the deficient anti-proteinase via intravenous infusion [2], [4]. The gene discussed is SERPINA1; the disease is lung disorder.